Similarly, Zhang et al. found that attenuating the MEK/ERK MAPK signaling pathway and downregulating HOXA5 expression in a mouse model effectively prevented pathological cardiac hypertrophy and HF [41]. This evidence concerns the gene MAPK1 and cardiac hypertrophy.